Satellos Bioscience Secures Patent for Forazapadin Drug
Satellos Bioscience has been granted a patent for forazapadin, enhancing its drug development strategy in the pharmaceutical industry.
Megan Holdings Regains Nasdaq Compliance After Share Split
Megan Holdings Ltd. regains compliance with Nasdaq's minimum bid price requirement following a share consolidation, crucial for its market presence.
Osisko Gold reports high-grade drilling results at Cariboo
Osisko Gold Group announces significant gold drilling results from its Cariboo Gold Project, enhancing its position in the gold and silver ores industry.
Dr. Reddy's Laboratories Reports Operational Update
Dr. Reddy's Laboratories has submitted a report detailing a significant operational update, impacting the pharmaceutical preparations industry.
Apex Critical Metals Reports High-Grade Drill Results
Apex Critical Metals Corp. announces significant drill results from its Trinity Zone, extending the area and revealing high-grade rare earth elements.
Trinity Biotech Reports Successful Annual General Meeting Results
Trinity Biotech PLC announces all resolutions passed at its annual general meeting, reflecting strong shareholder support and stability.
Anavex Receives FDA Approval for Blarcamesine Study
Anavex Life Sciences Corp. receives FDA clearance for its clinical study of blarcamesine in Fragile X syndrome, marking a milestone for the company.
CervoMed reports positive Phase 2a trial results for drug
CervoMed Inc. announces promising Phase 2a trial results for neflamapimod, showing potential in treating primary progressive aphasia.
Medline Inc. Board Member Joseph P. Baratta Resigns
Joseph P. Baratta resigns from Medline Inc. Board, effective December 31, 2026, aligning with his departure from Blackstone Inc.
Orion Group Holdings appoints new CFO Alison G. Vasquez
Orion Group Holdings has appointed Alison G. Vasquez as CFO, reflecting its commitment to strong leadership in the heavy construction sector.
Compass Minerals Board Shrinks Following Director Resignation
Compass Minerals International Inc. has reduced its Board size to eight members following the resignation of David Safran, effective October 9, 2026.
Co-Diagnostics Fails to Achieve Quorum at Annual Meeting
Co-Diagnostics, Inc. fails to achieve quorum at its annual meeting, impacting future governance decisions and raising concerns in the medical instruments industry.
Donegal Group Inc. Declares Quarterly Cash Dividend
Donegal Group Inc. announces a quarterly cash dividend of $0.1925 for Class A and $0.175 for Class B common stock, reflecting financial stability.
KiNRG, Inc. Amends Investor Presentation for Accuracy
KiNRG, Inc. corrects inaccuracies in its investor presentation, emphasizing transparency in its capital-raising efforts.
First Tracks Biotherapeutics Reports Positive Phase 1b Data
First Tracks Biotherapeutics shares positive topline data from its Phase 1b cohort of ANB033 in Celiac Disease, signaling growth potential in the pharmaceutical sector.
Gulf Resources to Resume Production at Bromine Factories
Gulf Resources, Inc. receives approval to restart production at two bromine factories, signaling a recovery for the company and the chemicals industry.
Quaint Oak Bancorp declares quarterly cash dividend
Quaint Oak Bancorp, Inc. announces a quarterly cash dividend of $0.04 per share, payable on November 9, 2026, to shareholders of record.
Edesa Biotech Receives FDA Clearance for EB06 Study
Edesa Biotech, Inc. has received FDA clearance for its Phase 2 clinical study of EB06 in vitiligo, expanding patient recruitment into the U.S.
ASP Isotopes Announces Joint Venture with Necsa for Uranium Production
ASP Isotopes Inc. partners with Necsa to develop a facility for High-Assay Low-Enriched Uranium production, marking a strategic move in the nuclear sector.
Allstate reports estimated catastrophe losses for September 2026
Allstate Corp discloses estimated catastrophe losses for September 2026, impacting its financial outlook and the broader fire, marine, and casualty insurance sector.